Stay updated on Appili Therapeutics Press Releases

Sign up to get notified when there's something new on the Appili Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Appili Therapeutics Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    Two new News entries were added: 'Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026' (Feb 12, 2026) and 'Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement' (Feb 18, 2026).
    Difference
    0.6%
    Check dated 2026-02-19T04:04:13.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    63 days ago
    Change Detected
    Summary
    A new news item dated December 18, 2025 — 'Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement' — appears with a Read More link.
    Difference
    0.3%
    Check dated 2025-12-23T21:42:41.000Z thumbnail image
  5. Check
    99 days ago
    Change Detected
    Summary
    A new news entry 'Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026' dated November 13, 2025 was added, along with a Read More link.
    Difference
    0.3%
    Check dated 2025-11-18T07:17:06.000Z thumbnail image
  6. Check
    106 days ago
    Change Detected
    Summary
    A new News item titled 'Appili Therapeutics Announces Proposed Non-Brokered Private Placement' with a Read More link and the date November 5, 2025 was added to the News page.
    Difference
    0.3%
    Check dated 2025-11-11T02:56:31.000Z thumbnail image
  7. Check
    113 days ago
    Change Detected
    Summary
    The 'Skip to content' link has been removed from the News page. This removes a keyboard shortcut to reach the main content.
    Difference
    0.1%
    Check dated 2025-11-03T21:13:32.000Z thumbnail image
  8. Check
    142 days ago
    Change Detected
    Summary
    New high-importance news item added: Appili Therapeutics and Vitalex Biosciences awarded a NIAID contract up to $40M to develop the fungal vaccine VXV-01.
    Difference
    4%
    Check dated 2025-10-06T06:36:08.000Z thumbnail image

Stay in the know with updates to Appili Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Appili Therapeutics Press Releases page.